Trial
NCT01835288
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
arsenic trioxide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-21